About Ankerite Pharmaceuticals Private Limited
Data last updated:
Ankerite Pharmaceuticals Private Limited is a private limited company based in Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 January 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24232UP2006PTC031249. Its GSTIN is 09AAFCA7346B1ZU (Uttar Pradesh).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors including Kirti Kumar and Sunil Rohatgi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Md 1\163 Dayakunjmansarover Lucknow, Uttar Pradesh, India.
As per MCA filings, the company has open charges of ₹2.9 Lakh on record. Court records list 1 case involving the company, including 1 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ankeritesuppliment.com.
Company details
Contact details
Ankerite Pharmaceuticals Private Limited's registered office is in Uttar Pradesh. Its website is ankeritesuppliment.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressMd 1\163 Dayakunjmansarover Lucknow, Uttar Pradesh, India
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Ankerite Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ankerite Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Ankerite Pharmaceuticals Private Limited, buy the company report.
Financials of Ankerite Pharmaceuticals Private Limited
FY 2025 filings availableAnkerite Pharmaceuticals Private Limited reported revenue of ₹52 (down 100% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 98% over three years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ankerite Pharmaceuticals Private Limited, buy the company report.
Board of directors of Ankerite Pharmaceuticals Private Limited
Ankerite Pharmaceuticals has 7 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kirti Kumar Also directs: Ankerite Health Care Private Limited | Director | 15 Dec 2008 | 17 Years 10 Months | Current |
| Sunil Rohatgi Also directs: Ankerite Health Care Private Limited | Director | 30 Sep 2009 | 17 Years 0 Months | Current |
| Reetika Rohatgi Also directs: Ankerite Health Care Private Limited | Director | 30 Sep 2009 | 17 Years 0 Months | Current |
| Kiran Rohatgi Also directs: Ankerite Health Care Private Limited | Director | 30 Sep 2009 | 17 Years 0 Months | Current |
| Ishan Arora Also directs: Bhaarat Infradevelopers LLP | Director | 11 Jun 2020 | 6 Years 4 Months | Current |
| Chandrabhan | Director | 11 Jun 2020 | 6 Years 4 Months | Current |
Auditor
Ankerite Pharmaceuticals Private Limited is audited by D S SINHA & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| D S SINHA & CO | FY 2019 | 005515C |
Shareholding
The shareholding of Ankerite Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Ankerite Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Feb 2018 | 100171340 | Others | ₹2.9 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Ankerite Pharmaceuticals Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Lucknow, Uttar Pradesh | Court case (Complaint Cases) | Filed against the company by an individual | Disposed |
To see the full case history of Ankerite Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ankerite Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ankerite Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAFCA7346B1ZU | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ankerite Pharmaceuticals Private Limited, buy the company report.
Recent activity
Ankerite Pharmaceuticals Private Limited has 9 board changes on record since 2006: 8 appointments and 1 cessation. The latest: Sunita Rohtagi ceased to be Director on 22 Nov 2021.
1 earlier event is in the company report.
Frequently asked questions
Ankerite Pharmaceuticals is an active private limited company based in Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 January 2006 (20+ years old) and is registered under CIN U24232UP2006PTC031249.
Ankerite Pharmaceuticals has 7 current directors:
- Kirti Kumar - Director
- Sunil Rohatgi - Director
- Reetika Rohatgi - Director
- Kiran Rohatgi - Director
- Ishan Arora - Director
- Chandrabhan - Director
- Karan Kathuria - Director
The latest financial statements of Ankerite Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Ankerite Pharmaceuticals is 09AAFCA7346B1ZU, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Ankerite Pharmaceuticals is U24232UP2006PTC031249. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ankerite Pharmaceuticals has 1 court case on record: 1 filed against it.
Ankerite Pharmaceuticals was incorporated on 23 January 2006, making it 20+ years old. It is registered with the Registrar of Companies, Kanpur.
Sunita Rohtagi ceased to be Director on 22 Nov 2021. Chandrabhan was appointed as Director on 11 Jun 2020. Ishan Arora was appointed as Director on 11 Jun 2020. Ankerite Pharmaceuticals has 9 board changes on record in total.
Ankerite Pharmaceuticals can be reached through the website ankeritesuppliment.com. Its registered office is in Uttar Pradesh, India.
The registered office of Ankerite Pharmaceuticals is at Md 1163 Dayakunjmansarover Lucknow, Uttar Pradesh, India.